Denmark · Delayed Price · Currency is DKK CPH:SMSMED Statistics
Total Valuation
CPH:SMSMED has a market cap or net worth of DKK 105.49 million. The enterprise value is 166.86 million.
| Market Cap | 105.49M |
| Enterprise Value | 166.86M |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPH:SMSMED has 27.69 million shares outstanding. The number of shares has increased by 0.67% in one year.
| Current Share Class | 27.69M |
| Shares Outstanding | 27.69M |
| Shares Change (YoY) | +0.67% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.16% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 4,057.21 and the forward PE ratio is 54.43.
| PE Ratio | 4,057.21 |
| Forward PE | 54.43 |
| PS Ratio | 0.43 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.03, with an EV/FCF ratio of -4.88.
| EV / Earnings | 6,417.86 |
| EV / Sales | 0.68 |
| EV / EBITDA | 16.03 |
| EV / EBIT | 93.27 |
| EV / FCF | -4.88 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.56 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 6.10 |
| Debt / FCF | -1.86 |
| Interest Coverage | 0.83 |
Financial Efficiency
Return on equity (ROE) is 0.03% and return on invested capital (ROIC) is 0.83%.
| Return on Equity (ROE) | 0.03% |
| Return on Assets (ROA) | 0.59% |
| Return on Invested Capital (ROIC) | 0.83% |
| Return on Capital Employed (ROCE) | 1.56% |
| Revenue Per Employee | 8.46M |
| Profits Per Employee | 897 |
| Employee Count | 29 |
| Asset Turnover | 1.29 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, CPH:SMSMED has paid 189,000 in taxes.
| Income Tax | 189,000 |
| Effective Tax Rate | 87.91% |
Stock Price Statistics
The stock price has decreased by -37.95% in the last 52 weeks. The beta is 0.49, so CPH:SMSMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -37.95% |
| 50-Day Moving Average | 4.19 |
| 200-Day Moving Average | 4.52 |
| Relative Strength Index (RSI) | 42.47 |
| Average Volume (20 Days) | 38,539 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CPH:SMSMED had revenue of DKK 245.44 million and earned 26,000 in profits. Earnings per share was 0.00.
| Revenue | 245.44M |
| Gross Profit | 34.28M |
| Operating Income | 1.79M |
| Pretax Income | 215,000 |
| Net Income | 26,000 |
| EBITDA | 10.41M |
| EBIT | 1.79M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 2.15 million in cash and 63.53 million in debt, giving a net cash position of -61.38 million or -2.22 per share.
| Cash & Cash Equivalents | 2.15M |
| Total Debt | 63.53M |
| Net Cash | -61.38M |
| Net Cash Per Share | -2.22 |
| Equity (Book Value) | 82.67M |
| Book Value Per Share | 2.99 |
| Working Capital | 50.78M |
Cash Flow
In the last 12 months, operating cash flow was -13.41 million and capital expenditures -20.81 million, giving a free cash flow of -34.22 million.
| Operating Cash Flow | -13.41M |
| Capital Expenditures | -20.81M |
| Free Cash Flow | -34.22M |
| FCF Per Share | -1.24 |
Margins
Gross margin is 13.97%, with operating and profit margins of 0.73% and 0.01%.
| Gross Margin | 13.97% |
| Operating Margin | 0.73% |
| Pretax Margin | 0.09% |
| Profit Margin | 0.01% |
| EBITDA Margin | 4.24% |
| EBIT Margin | 0.73% |
| FCF Margin | n/a |
Dividends & Yields
CPH:SMSMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.67% |
| Shareholder Yield | -0.67% |
| Earnings Yield | 0.02% |
| FCF Yield | -32.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPH:SMSMED has an Altman Z-Score of 2.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 2 |